Verdad Advisers »

Terns Pharmaceuticals shares owned by Verdad Advisers

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $701k 13k 52.72

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
venBio Select Advisor
Vanguard Capital Management
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management
Glazer Capital
Paradigm Biocapital Advisors

View all funds holding Terns Pharmaceuticals